Published • loading... • Updated
Latham & Watkins Advises EQT in Acquisition of TachoSil® Biosurgery Business from Corza Medical
Summary by Legal Desire
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Latham & Watkins Advises EQT in Acquisition of TachoSil® Biosurgery Business from Corza Medical
EQT has announced that EQT X has agreed to acquire Corza Biosurgery from Corza Medical, comprising... The post Latham & Watkins Advises EQT in Acquisition of TachoSil® Biosurgery Business from Corza Medical appeared first on Legal Desire Media and Insights.
Deal Roundup: GTCR agrees Corza Biosurgery sale to EQT, Lone Star agrees €4bn ContiTech buyout
GTCR has agreed to sell the Biosurgery business of Corza Medical, including the TachoSil product portfolio, to EQT, six years after forming the company. The post Deal Roundup: GTCR agrees Corza Biosurgery sale to EQT, Lone Star agrees €4bn ContiTech buyout appeared first on AltAssets Private Equity News.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
